With rising interest rates, slumping oil prices, a strong dollar, and economic pressures in China, 2016 is shaping up to be a challenging year for U.S. publicly-traded companies. In the coming week, 56 S&P 500 component companies are expected to report results for the quarter that ended in December. Overall, S&P 500 EPS are forecast to fall by 6%, according to Factset, yet the companies on our list today could surprise to the upside.
F5 Networks Inc. (NASDAQ: FFIV) – $93.52
IT Services & Consulting
F5 Networks, Inc. is the developer and provider of application delivery services. The Company’s core technology is a full-proxy, programmable, software platform called TMOS (Traffic Management Operating System). It helps organizations seamlessly scale cloud, data center, and software-defined networking deployments to successfully deliver applications to anyone, anywhere, at any time. It works with many technology companies to improve manageability, strengthen security, and ensure faster and more successful deployments.
-
Market Cap: $6,581,791,335
-
Expected Report Date: 20/01/2016
-
Expected Quarterly EPS Y/Y increase: 32.0%
-
Earnings Per Share – Mean Estimate: $1.60
Alaska Air Group Inc. (NYSE: ALK) – $68.73
Airlines
Alaska Air Group, Inc. is a holding company of Alaska Airlines Inc. (Alaska) and Horizon Air Industries Inc. (Horizon). The Company operates Alaska Airlines and Horizon Air airlines, which together with its partner regional airlines serve approximately 100 cities through a network in Alaska, the Lower 48, Hawaii, Canada and Mexico. The Company operates in three segments: Alaska Mainline, Alaska Regional and Horizon.
-
Market Cap: $8,668,819,640
-
Expected Report Date: 21/01/2016
-
Expected Quarterly EPS Y/Y increase: 25.6%
-
Earnings Per Share – Mean Estimate: $1.40
Intuitive Surgical Inc. (NASDAQ: ISRG) – $557.25
Advanced Medical Equipment & Technology
Intuitive Surgical, Inc. designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation and three-dimensional (3-D), high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures.
-
Market Cap: $20,821,763,273
-
Expected Report Date: 21/01/2016
-
Expected Quarterly EPS Y/Y increase: 24.0%
-
Earnings Per Share – Mean Estimate: $5.00
TransDigm Group Inc. (NYSE: TDG)– $218.26
Aerospace & Defense
TransDigm Group Incorporated (TransDigm) is a designer, producer and supplier of engineered aircraft components for use on commercial and military aircraft. The Company operates through three segments: Power & Control, Airframe and Non-aviation.
-
Market Cap: $11,717,822,400
-
Expected Report Date: 25/01/2016
-
Expected Quarterly EPS Y/Y increase: 41.3%
-
Earnings Per Share – Mean Estimate: $2.30
Amgen Inc. (NASDAQ: AMGN) – $151.30
Biotechnology & Medical Research
Amgen Inc. (Amgen) is a biotechnology company that is engaged in discovering, developing, manufacturing and delivering human therapeutics. The Company’s sales and marketing forces are located in the United States and Europe. In the United States, it sells its products to pharmaceutical wholesale distributors. The Company also markets certain products directly to consumers through direct-to-consumer print and television advertising, as well as through the Internet.
-
Market Cap: $114,129,806,126
-
Expected Report Date: 25/01/2016
-
Expected Quarterly EPS Y/Y increase: 34.4%
-
Earnings Per Share – Mean Estimate: $2.28
DISCLAIMER The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.
